These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11920207)

  • 1. Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia.
    Leotard S; Chastang C; Travade P; Jaudon MC; Tournilhac O; Baudet S; Merle-Beral H
    Hematol J; 2000; 1(5):301-6. PubMed ID: 11920207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
    Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
    Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta2-microglobulin in B-cell chronic lymphocytic leukemia.
    Molica S; Levato D; Cascavilla N; Levato L; Musto P
    Eur J Haematol; 1999 Feb; 62(2):117-22. PubMed ID: 10052715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of soluble CD23 in B-cell chronic lymphocytic leukemia.
    Saka B; Aktan M; Sami U; Oner D; Sanem O; Dinçol G
    Clin Lab Haematol; 2006 Feb; 28(1):30-5. PubMed ID: 16430457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
    Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
    Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic significance of lactate dehydrogenase and beta2-microglobulin in chronic lymphocytic leukemia].
    Shen QD; Xu W; Yu H; Li L; Zhang SJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1305-8. PubMed ID: 18088490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic lymphocytic leukemia and prognostic factors.
    Mozaheb Z; Hasanzadeh NazarAbadi MH; Aghaee MA
    Asian Pac J Cancer Prev; 2012; 13(7):3009-13. PubMed ID: 22994703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evolution of chronic lymphocytic leukemia: predictive value of immunophenotype, soluble CD23 and morphology].
    Sarmientó MA; Palacios MF; Scolnik MP; Ramírez FR; Stanganelli C; Cabrera J; Chena CP; Arrossagaray G; Slavutsky IR; Bengió RM
    Medicina (B Aires); 2002; 62(4):305-12. PubMed ID: 12325485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia.
    Beguin Y; Lampertz S; De Groote D; Igot D; Malaise M; Fillet G
    Leukemia; 1993 Dec; 7(12):2019-25. PubMed ID: 8255102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
    Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience.
    Molica S; Mauro FR; Callea V; Giannarelli D; Lauria F; Rotoli B; Cortelezzi A; Liso V; Foà R
    Haematologica; 2010 Mar; 95(3):464-9. PubMed ID: 19903673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinico-biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia.
    Molica S; Vitelli G; Levato D; Levato L; Dattilo A; Gandolfo GM
    Haematologica; 1999 Mar; 84(3):208-11. PubMed ID: 10189383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early chronic lymphocytic leukemia: prognostic value of quantitative bone marrow MR imaging findings and correlation with hematologic variables.
    Lecouvet FE; Vande Berg BC; Michaux L; Schmitz PJ; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
    Radiology; 1997 Sep; 204(3):813-8. PubMed ID: 9280265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
    Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
    Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia.
    Piñeyroa JA; Magnano L; Rivero A; Rivas-Delgado A; Nadeu F; Correa JG; Giné E; Villamor N; Filella X; Colomer D; López M; López-Oreja I; Costa D; Aymerich M; Beà S; López-Guillermo A; Campo E; Delgado J; Mozas P
    Hematol Oncol; 2022 Oct; 40(4):588-595. PubMed ID: 35611996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.